Validation of prostate SABR with dominant intra-prostatic lesion (DIL) boost regions using a bespoke 3D-printed modular pelvis phantom.

Raymond King, Craig McCreery, Prakash Jeevanandam, A.R. Hounsell, Suneil Jain, Fraser Buchanan, Conor McGarry

Research output: Contribution to conferenceAbstractpeer-review

Abstract

Purpose/Objective Patients with prostate cancer are increasingly receiving a boost dose to dominant intra-prostatic lesions (DILs) as part of their radiotherapy treatment. However, validation of the dose to the boost region is challenging due to its small volume. The aim of this project was to 3D print a patient-specific phantom to validate prostate SABR boost plans. Material and Methods The patient body outline and bone structure were segmented on their CT scan using the Eclipse treatment planning system. A cylindrical module was added at the location of the prostate and used to encapsulate dosimeters (film and pinpoint ionization chamber (PP)). Each element was printed using a RepRap X400 3D printer. The bone was printed using Stonefil filament with variable infill. The pelvis and dosimetry inserts were printed as shells using PETG and filled with water. A SABR plan was delivered to the phantom with film placed through the boost region and a PP placed at positions within the prostate and boost regions. The films were compared to the dose calculation using FilmProQA with global gamma analysis performed using a 2%/2mm criteria and 10% threshold. The plans were recalculated on the phantom and directly compared with the original patient plan using the Verisoft software (global gamma analysis at 1%/1mm and 10% threshold). Results Outlines of the external contour and the bones were consistent between the phantom and patient CT scans. Dose comparisons between the phantom and patient plan calculation revealed 99.0±0.3% of pixels were within 1%/1mm. Prostate and boost point doses were within ±1.5% of expected. Pass rates for film were > 91% at 2%/2mm and > 98.5% at 3%/3mm, with failure regions coinciding with air gaps between the slices of the phantom. Conclusion A bespoke pelvic phantom was designed, constructed and validated to ensure the safe delivery of SABR prostate boost plans. Keywords: Dose verification, Prostate SABR, DILs, 3D Printing
Original languageEnglish
Publication statusPublished - 21 Feb 2020
EventScottish+ 2020 Radiotherapy Physics Meeting - Scotland, Edinburgh, United Kingdom
Duration: 21 Feb 202021 Feb 2020

Conference

ConferenceScottish+ 2020 Radiotherapy Physics Meeting
Country/TerritoryUnited Kingdom
CityEdinburgh
Period21/02/202021/02/2020

Fingerprint

Dive into the research topics of 'Validation of prostate SABR with dominant intra-prostatic lesion (DIL) boost regions using a bespoke 3D-printed modular pelvis phantom.'. Together they form a unique fingerprint.

Cite this